The United States Patent and Trademark Office (USPTO) has renewed the trademark '3DTHYROID' (TM87140187), originally filed on August 16, 2016. The renewal is effective March 22, 2026, and pertains to a range of services including scientific and medical research in the field of endocrine disorders, provision of medical information, and specialized three-dimensional imaging of the thyroid for use in ultrasound-guided needle biopsies to determine malignancy.

This renewal signifies the continued protection of intellectual property for services supporting endocrine disorder research and diagnostics. While this is a trademark renewal and not a new regulatory requirement, entities operating in the medical research and diagnostic imaging space, particularly those focused on endocrinology and thyroid conditions, should be aware of the scope of protected services. No immediate compliance actions are required for regulated entities, but it highlights the importance of intellectual property management in the healthcare technology sector.